Metronidazole Treatment Guidelines

Introduction to Metronidazole

Metronidazole is indicated for trichomoniasis, bacterial vaginosis, amebiasis, giardiasis, and anaerobic bacterial infections, with specific dosing regimens for each condition 1, 2

The Centers for Disease Control and Prevention recommends first-line treatment with Metronidazole 500 mg orally twice daily for 7 days, which has a preferred regimen with 90-95% cure rate 1, 2
Alternative regimen: Metronidazole 2 g orally in a single dose, as recommended by the CDC 3, 2
All sexual partners should be treated simultaneously to prevent reinfection, as advised by the CDC 2
Routine follow-up is unnecessary if symptoms resolve, according to the CDC 2
For treatment failure, the CDC recommends re-treating with metronidazole 500 mg twice daily for 7 days 2
In cases of repeated failure, the CDC suggests metronidazole 2 g once daily for 3-5 days 3, 2

The CDC recommends metronidazole 500 mg orally twice daily for 7 days 4
The CDC also recommends metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once daily for 5 days 4
Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days is an alternative regimen, as recommended by the CDC 4
Metronidazole 2 g orally in a single dose has lower efficacy, according to the CDC 4
Clindamycin 300 mg orally twice daily for 7 days is another alternative, as recommended by the CDC 4
Clindamycin ovules 100 g intravaginally once at bedtime for 3 days is also an option, according to the CDC 4

In pregnancy, metronidazole is contraindicated in the first trimester, as recommended by the CDC and the American College of Obstetricians and Gynecologists 5, 1
For trichomoniasis in the second and third trimesters, the CDC recommends 2 g orally in a single dose 3, 1
For bacterial vaginosis in the second and third trimesters, oral metronidazole can be used, but vaginal metronidazole gel or clindamycin cream may be preferable, according to the CDC and the American College of Obstetricians and Gynecologists 5
HIV-infected individuals should receive the same treatment regimens as HIV-negative individuals, as recommended by the CDC and the Infectious Diseases Society of America 1, 2

Patients should avoid alcohol during treatment with metronidazole and for 24 hours afterward due to disulfiram-like reaction, as advised by the CDC and the American Medical Association 4
Metronidazole gel is NOT recommended for trichomoniasis treatment, despite its approval for bacterial vaginosis, due to efficacy <50% compared to oral therapy, according to the CDC and the American Medical Association 3, 2
For patients with metronidazole allergy, options are limited, and desensitization may be considered, as recommended by the CDC and the American Academy of Allergy, Asthma, and Immunology 1, 2